#USA #New York #Levi Korsinsky #TransMedics Group #TMDX

Attention TransMedics Group, Inc. Investors

TransMedics Group, Inc. (NASDAQ: TMDX) investors who have experienced losses are being urged to take action regarding a class action securities lawsuit filed by Levi & Korsinsky, LLP. This notification serves as a significant opportunity for affected shareholders to seek recovery for their losses.

Important Details Regarding the Class Action

The class action claims aim to find restitution for investors harmed by alleged securities fraud committed by TransMedics between February 28, 2023, and January 10, 2025. During this period, it is alleged that the company made misleading statements and concealed critical operational issues. Here are the key allegations:
1. Fraudulent Practices: The lawsuit asserts that TransMedics engaged in kickbacks and fraudulent overbilling to elevate their business and revenues.
2. Safety Concerns: Allegations include the company's engagement in unsafe practices and failure to disclose safety issues, which led to a lack of proper oversight.
3. Regulatory Scrutiny: Due to the aforementioned issues, the company faced a heightened risk of regulatory scrutiny, which was not communicated to investors.
4. Misleading Information: Consequently, the statements made by the company's executives regarding business operations and future prospects were claimed to be materially deceptive.

Next Steps for Investors

Affected investors are encouraged to act swiftly. They have until April 15, 2025, to request the Court to appoint them as lead plaintiff in the class action. However, participation is not limited to lead plaintiffs; any affected investor can still share in potential compensation. Importantly, there is no cost or fee for participating in the lawsuit, which allows investors to seek recovery without out-of-pocket expenses.

To learn more, investors can visit Levi & Korsinsky’s dedicated page to submit their information. Furthermore, questions can also be directed to attorney Joseph E. Levi via email or phone for guidance.

Why Choose Levi & Korsinsky?

For over two decades, Levi & Korsinsky has represented investors effectively, achieving substantial financial recoveries. They are known for their expertise in complex securities litigation, which has led to recognition as one of the top securities litigation firms in the United States multiple times. Their dedicated team works diligently to ensure that shareholders are represented in significant cases, including this one against TransMedics.

Contact Information

Investors wishing to engage further in this class action should reach out to Levi & Korsinsky, LLP. Direct communication can be established via:

• - Email: [email protected]
• - Telephone: (212) 363-7500
• - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004

Conclusion

If you have incurred losses as an investor in TransMedics Group, Inc., now is the time to act. The findings set forth suggest a serious disregard for investor knowledge by company officials. Join Levi & Korsinsky in seeking justice and recouping your financial losses through this class action lawsuit.